Matinas BioPharma Holdings, Inc.
General ticker "MTNB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $18.7M (TTM average)
Matinas BioPharma Holdings, Inc. does not follow the US Stock Market performance with the rate: -27.0%.
Estimated limits based on current volatility of 5.5%: low 0.63$, high 0.70$
Factors to consider:
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.59$, 2.44$]
- 2025-12-31 to 2026-12-31 estimated range: [0.75$, 2.47$]
Short-term MTNB quotes
Long-term MTNB plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $3.19MM | $1.10MM | $0.00MM |
| Operating Expenses | $27.78MM | $24.86MM | $24.59MM |
| Operating Income | $-24.59MM | $-23.77MM | $-24.59MM |
| Non-Operating Income | $3.59MM | $0.82MM | $0.34MM |
| R&D Expense | $16.68MM | $14.49MM | $11.43MM |
| Income(Loss) | $-21.00MM | $-22.94MM | $-24.25MM |
| Profit(Loss)* | $-13.02MM | $-22.94MM | $-24.25MM |
| Stockholders Equity | $36.64MM | $19.25MM | $7.59MM |
| Assets | $44.82MM | $25.10MM | $12.64MM |
| Operating Cash Flow | $-19.16MM | $-15.28MM | $-15.88MM |
| Capital expenditure | $0.89MM | $0.22MM | $0.00MM |
| Investing Cash Flow | $4.88MM | $13.24MM | $9.21MM |
| Financing Cash Flow | $0.08MM | $-0.01MM | $9.17MM |
| Earnings Per Share** | $-3.00 | $-5.28 | $-4.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.